Status:
TERMINATED
Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Inflammatory Bowel Diseases
Crohn's Disease
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if the program that has been made to ease the transition of care for adolescent patients with IBD from pediatric gastroenterology to adult gastroenterology is...
Detailed Description
Approximately 15 to 25% of patients with inflammatory bowel disease are diagnosed prior to the age of 18. The chronic course of this disease means that approximately one quarter of all IBD patients wi...
Eligibility Criteria
Inclusion
- A patient may be considered for study participation if all of the following apply:
- Outpatient of either sex aged ≥ 16 years or older.
- The patient has a confirmed diagnosis of IBD.
- No plans to move \> 200 miles from Nashville in the subsequent 12 months.
- The patient has read, understood and signed a written informed consent form. Permission of a minor participant will be obtained via a parent consent form.
Exclusion
- The patients will be excluded from the study if one or more of the following apply:
- Unable to give consent.
- Does not meet inclusion criteria above.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00360022
Start Date
August 1 2006
End Date
February 1 2011
Last Update
April 4 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Vanderbilt Clinic
Nashville, Tennessee, United States, 37232-5280
2
Vanderbilt Childrens Hospital/ Pediatric Gastroenterology Clinic
Nashville, Tennessee, United States, 37232